We have identi®ed a 360 kb YAC that carries a cell senescence gene, SEN16. In our earlier studies, we localized SEN16 within a genetic interval of 3 ± 7 cM at 16q24.3. Six overlapping YACs spanning the chromosomal region of senescence activity, were assembled in a contig. Candidate YACs, identi®ed by the markers located in the vicinity of SEN16, were retro®tted to introduce a neo selectable marker. Retro®tted YACs were ®rst transferred into mouse A9 cells to generate A9/YAC hybrids. YAC DNA present in A9/YAC hybrids was further transferred by microcell fusion into immortal cell lines derived from human and rat mammary tumors. YAC d792t2 restored senescence in both human and rat mammary tumor cell lines, while an unrelated YAC from chromosome 6q had no senescence activity. Oncogene (2000) 19, 217 ± 222.
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Keywords: cell senescence; breast cancer; YAC contig; YAC transfer; functional complementation Frequent loss of heterozygosity (LOH) on the long arm of chromosome 16 has been observed in a wide variety of breast tumors including tumors of non-invasive histological atypia as well as the more advanced phenotypes (Tsuda et al., 1994; Radford et al., 1995) . Three regions on 16q (16q22.1 ± 16q22.2, 16q23.1 ± 16q23.3 and 16q24.3-qter) show a high incidence of allelic imbalance in breast tumors, suggesting the presence of multiple growth suppressor genes on this chromosomal arm (Devilee et al., 1991; Cleton-Jansen et al., 1994; Tsuda et al., 1994; Devilee and Cornelisse, 1994; Skirnisdottir et al., 1995) . The most frequent LOH has been observed at 16q24.3-qter irrespective of the stage of the disease (Tsuda et al., 1994; Devilee and Cornelisse, 1994) , implicating a key early role for this region in breast carcinogenesis. Introduction of chromosome 16 or segments of 16q into human and rat mammary tumor cells led to the restoration of replicative senescence (Reddy et al., 1999) . Using this functional assay, cellular senescence genes have been identi®ed on at least ten dierent human chromosomes (reviewed in Oshimura and Barrett, 1997) .
Escape from senescence in tumor cells has been postulated to be an early step in the evolution of malignant tumors (O'Brien et al., 1986; Medina, 1996; Yeager et al., 1998) . So far only one gene, MORF4, which restores senescence in immortal Hela cells has been cloned (Bertram et al., 1999) . However, the role of this gene in cellular senescence has not been established as yet.
We have devised an experimental strategy, applying chromosome transfer into human and rodent cell lines in parallel, for the high resolution mapping of cell senescence/tumor suppressor genes (Reddy et al., 1999; Sandhu et al., 1996) . Using this approach, we mapped a cell senescence gene, SEN16, within a 3 ± 7 cM genetic interval at 16q24.3 (Reddy et al., 1999) . This mapping resolution allowed us to identify a small number of Yeast Arti®cial Chromosome (YAC) clones to construct a physical map across the 3 ± 7 cM region at 16q24.3. We have now used functional analysis, by introduction of YAC DNA into human and rat mammary tumor cell lines, to identify a 360 Kb YAC that carries SEN16. This report describes the construction of a partial YAC contig spanning the 3 ± 7 cM region at 16q24.3, that previously identi®ed to carry SEN16, and provide functional evidence for the presence of SEN16 on a 360 Kb YAC, d792t2.
Six YACs, 624H7(400 kb), 706H5(420 kb), 707F9(1770 kb), 720E2(450 kb), 792E1(360 kb), and 897G6(1420 kb), each carrying at least one marker mapped in the vicinity of the senescence gene, were identi®ed from a Human Genome database (www.genome.wi.mit.edu/) and a published map of chromosome 16 (Doggett et al., 1995) . Each of the six YACs were analysed for the presence or absence of 40 DNA markers mapped at 16q24. These data allowed us to identify overlaps among dierent YAC clones and to assemble a contiguous physical map of the region (Figure 1 ) and also to determine the relative order of various markers associated with SEN16 ( Figure 1) . Three overlapping YACs, 624H7, 792E1 and 897G6, carried 14 out of 21 markers associated with the senescence activity (Figure 1 ), while seven markers, D16S305, 449, 498, 520, 2727 , 2733 and WI-16080 (Reddy et al., 1999 did not map to any of the YACs analysed. The remaining three YACs carried markers which have been mapped away from consensus region of senescence activity. Based upon our previous results on the mapping of SEN16, 624H7 and 792E1 were considered most likely to carry SEN16.
Since replicative senescence is a dominant phenotype, YACs were screened for the induction of senescence by introduction into immortal human (MCF.7) and rat (LA7) mammary tumor cell lines. 624H7 and 792E1 were retro®tted to incorporate a neo marker, for selection in mammalian cells (Markie et al., 1993) . Retro®tted clones were analysed by pulsed ®eld gel electrophoresis (PFGE) and Southern blot hybridization to determine the size of the derivative clones, in comparison with the parental YACs. All derivative clones of 624H7 retained the human insert of the parental YAC. However, in case of 792E1, two derivative clones, d792t2 and d792t3, each of dierent size, were obtained ( Figure 1 ).
Analysis for the presence of markers located on 792E1 revealed that d792t2 retained six markers i.e. D16S3028, 3048, 3063, 3077, WI-12410 and 15838, while d792t3 retained only four markers i.e. D16S3028, 3048, 3063 and 3077 ( Figure 1 ).
YACs have been transferred eciently into mouse (Pavan et al., 1990; Pachnis et al., 1990; Huxley et al., 1991; Eliceiri et al., 1991; Strauss and Jaenisch, 1992; Peterson et al., 1993; Perou et al., 1996; Koreth et al., 1999) and Chinese hamster cells (Gnirke et al., 1991) by spheroplast fusion but only a few studies have reported successful transfer into human cells (Wada et al., 1994; Julicher et al., 1997; Murakami et al., 1998) . Thus, not every cell line is amenable to this method. In our studies, spheroplast fusion (Davies and Huxley, 1996) of YACs with A9, a mouse cell line, was highly ecient. Despite repeated attempts with a variety of protocols, the transfer of YAC DNA into human or rat mammary tumor cells was not successful. In order to circumvent this technical problem, we have applied a two step process for the transfer of YAC DNA into desired cell lines. YAC DNA was ®rst transferred into A9 cells by spheroplast fusion and the chromosome carrying the integrated YAC was further transferred to mammary tumor cells by microcell fusion (Athwal et al., 1985; Sandhu et al., 1996) . Microcell hybrids were analysed for growth and morphological alterations indicative of senescence. Since YAC d792t2 carried the most markers associated with SEN16, including two expressed sequence tags(ESTs), it was considered the most likely candidate to carry SEN16 and thus was selected for transfer into A9 cells. Eight colonies, designated A9/ d792t2-(1 to 8), were recovered under G418 selection, following the transfer of d792t2 into A9 cells. As expected, introduction of d792t2 did not aect the morphology or growth characteristics of A9 cells. Analysis of all eight colonies for human markers revealed that six of the clones carried all the markers present on d792t2, while two clones did not contain any human markers (data not shown). One A9/YAC hybrid, A9/d792t2-4, which contained all human markers from d792t2, was used as microcell donor to transfer d792t2 into MCF.7 and LA7 cells. A total of 25 and 60 microcell hybrid colonies were recovered from MCF.7 and LA7 cells in G418 selection (Table 1) .
Cells in all MCF/d792t2 and LA/d792t2 colonies displayed enlarged,¯at and vacuolated morphology, identical to the phenotypes previously observed following the introduction of intact chromosome 16 into these cells (Figure 2 ; Reddy et al., 1999) . All colonies expressed progressively increasing doubling time (or diminishing growth rate), which varied from 72 ± 96 h for MCF/ d792t2 and 48 ± 72 h for LA/d792t2 cells, eventually ending in complete growth arrest. At the time of complete growth arrest, senescent colonies each contained between 250 and 2000 cells which remained attached to the surface in a nondividing state for an additional 4 ± 8 weeks (Table 1 ). In comparison, parental tumor cells and segregant clones displayed a doubling time of 30 and 18 h in human and rat cells respectively.
In control experiments, YAC 966B10, which maps to a region of chromosome 6 devoid of senescence activity (RS Athwal, unpublished results), was transferred into MCF.7 and LA7 cells, through A9 cells by microcell fusion. Four MCF.7/966B10 and eight LA7/966B10 transfer clones, recovered in G418 selection medium, displayed inde®nite proliferation and cell morphology identical to the parental cells (Figure 2 ). The eect of mouse A9 chromosomes on the senescent phenotype is considered unlikely since whole cell hybrids between A9 cells and rat ovarian and brain tumor cells are invariably immortal and the fact that dierent mouse chromosomes are transferred along with human YAC or segments of human chromosomes in independent experiments (GP Kaur, unpublished observations).
Senescent and immortal microcell hybrids were also examined for the expression of senescence associated (SA) pH 6.0 activity (Dimri et al., 1995) in comparison with parental cell lines. These data revealed that senescent cells of LA/d792t2 and MCF/d792t2 hybrid clones stained blue, typical of senescent cells expressing the expected b-gal activity at pH 6.0 (Figure 3) . In contrast, b-galactosidase activity was not expressed by parental tumor cells, LA/966B10 or MCF/966B10 hybrids or segregant clones. All senescent microcell hybrids of rat (LA/d792t2) and human (MCF/d792t2) cells carried a neo marker. The neo marker was detected by PCR as a 500-bp amplimer using primers U2056 (GCAATAT-CACGGGTAGCCAACG) and L2562 (GTCCGG-TGCCCTGAATGAACTG). LA/d792t2 clones were also positive for all human markers (D16S3028, 3048, 3063, 3077, WI-12410 and 15838) present on the donor YAC (data not shown). However, donor alleles could not be documented in MCF/d792t2 hybrids because of the lack of polymorphism between donor YAC and recipient host cell alleles. All LA/966B10 and MCF.7/ 966B10 hybrid colonies were positive for the neo marker and D6S434, a chromosome 6 speci®c marker.
Pre-senescent cells from human and rat microcell hybrids were placed in non-selective medium to promote random segregation of the introduced chromosome carrying the integrated YAC. Clones displaying morphology and growth properties similar to the parental tumor cells, were isolated. These segregant clones were negative for the neo marker and failed to grow in G418 medium. Segregant clones of LA7 hybrids also showed the loss of chromosome 16 speci®c human markers, while segregants of MCF.7 hybrids could not be examined for the donor markers because of the lack of polymorphism. Reversion to immortal growth, concordant with the loss of the donor DNA, con®rms that restoration of senescence in tumor cells requires the transfer and retention of the donor YAC.
Since YACs often contain DNA fragments originating from more than one chromosome, d792t2 was examined for chimerism by Fluorescent in situ hybridization (FISH) to metaphase spreads of normal human lymphocytes. d792t2 mapped to chromosomal positions at 16q24.3 and 11q13 (Figure 4 ). Alu-PCR ampli®ed human DNA from hybrid A9/d792t2-4, the microcell donor clone, also mapped to the identical position. These data revealed that DNA sequences from chromosomes 11 and 16 carried in d792t2 are retained in A9/d792t2 and were transferred to mammary tumor cells. Since intact chromosome 11 does not restore senescence in MCF.7 or LA7 cells (Negrini et al., 1994, RS Athwal unpublished observations) , the role of DNA sequences from chromosome 11, in senescence is ruled out.
In conclusion, we have identi®ed a 360 Kb YAC d792t2 that carries SEN16. The introduction of d792t2 restored senescence to both human and rat mammary tumor cell lines. Recipient tumor cells carrying donor YAC DNA were able to undergo 8 ± 10 population doublings before entering a state of complete growth arrest. This residual growth potential allows sucient expansion of YAC transfer clones to identify viable colonies, to examine for growth and morphological alterations, to extract DNA for PCR analysis and to allow segregation of donor YAC sequences. Reversion to inde®nite proliferation, concordant with the loss of the introduced YAC DNA, con®rmed that restoration of senescence is indeed related to the introduction and retention of the transferred DNA sequences. In contrast, a YAC(966B10) from another genomic region, had no eect on growth characteristics of recipient cells.
Our studies illustrate the usefulness of a functional complementation approach to analyse the role of any genomic region implicated in tumor suppression, Figure 4 A metaphase spread of normal human chromosomes showing FISH of YAC d792t2 at 16q24.3 and 11q13. Alu-PCR ampli®ed human DNA sequences (Munroe et al., 1994) from YAC clones and A9/YAC hybrid were used as probe for FISH. Biotin or digoxigenin-labeled probes were hybridized to human metaphase chomosomes derived from PHA-stimulated peripheral blood cultures. The conditions of hybridization, signal detection, digital-image acquisition, processing and analysis as well as the procedure for direct visualization of¯uorescent signal to labeled chromosomes were carried out as previously described (Popescu et al., 1994; Zimonjic et al., 1995) identi®ed either by chromosome transfer or by loss of heterozygosity. Although allelic losses are indicative of presence of tumor suppressor or growth regulatory genes, only a functional approach can determine if such putative genes are related to inhibition of cell growth and/or cell senescence or suppression of tumorigenicity or metastasis (reviewed in Oshimura and Barrett, 1997; Goyette et al., 1992; Negrini et al., 1994) . Recently, a minimal deleted region of 960 kb at 16q24.3 has been identi®ed from LOH data (Whitmore et al., 1998a) . However, transcript analysis of this region, between D16S3026 and D16S303, and thus outside the region of SEN16, did not indicate presence of any tumor suppressor gene for breast cancer (Whitmore et al., 1998b) . We have successfully used a functional mapping approach, ®rst to identify a 3 ± 7 cM region at 16q24.3 and then a genomic fragment of 360 kb that contains a cellular senescence gene, SEN16.
Since introduction of chromosome 16q23-qter also restores replicative senescence in immortal cell lines derived from hepatoma, prostate, ovarian tumors and SV40 transformed cells (RS Athwal, unpublished results), a defect in SEN16 may be common to many dierent tumors. Elucidation of the role of SEN16 in cell immortalization and tumorigenesis awaits cloning and characterization of this gene.
